Skip to content

Restructuring Charges at other companies

Repligen logo
RepligenRGEN
$1.5M-24.2%
Personalis, Inc. logo
Personalis, Inc.PSNL
$4.04M
Charles River Laboratories logo
Charles River LaboratoriesCRL
$31.58M+32.4%
Azenta logo
AzentaAZTA
$1.42M-60.3%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
Revvity logo
RevvityRVTY

Segments

By segment

See full
TriLink-$446K-168%
Corporate$9K
Cygnus-$3K-124%

Other financials

Income statement

See full
Revenue$65.8M+40.5%
Gross profit$33.7M+336%
Operating income-$2.2M+95.6%
Net income-$3.7M+87.5%
EPS (diluted)-$0.02+90.5%

Balance sheet

See full
Cash & equivalents$165.9M-41.8%
Total debt$270.9M-17.1%
Total equity$211.6M-29.6%
Total assets$713.2M-25.7%

Cash flow

See full
Operating cash flow$8.7M+192%
CapEx$4.4M-1.4%
Free cash flow$4.2M+130%

Valuation

See full
Market cap$849.64M+186%
Enterprise value$954.59M+182%
P/S4.2×+2.9×

Profitability

See full
Gross margin29.3%-8.0pp
Operating margin-82.2%-16.6pp
Net margin-51.1%-9.9pp
FCF margin-25.7%

Returns & leverage

See full
Return on equity-40.8%-4.0pp
Debt / equity1.3×+0.2×
Current ratio5.9×-0.1×

Where this comes from

Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RestructuringCharges.

The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Maravai LifeSciences Holdings, Inc.'s restructuring charges.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Maravai LifeSciences Holdings, Inc.'s restructuring charges?
Maravai LifeSciences Holdings, Inc. (MRVI) reported restructuring charges of $2.88M in Q1 2026.
What does restructuring charges mean?
One-time costs from reorganizing operations, including employee severance, facility closure costs, contract termination fees, and asset relocation expenses.